23 May 2013
Keywords: wyeth, ends, scolr, license, deal, pharma, developer
Article | 19 March 2007
SCOLR Pharma, a developer of over-the-counter drugs, says that fellow USA-based firm Wyeth is terminating a license agreement, under which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.